Juliane Morando
AuthID: R-00J-MBA
1
TITLE: Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available Full Text
AUTHORS: Lynda Foltz; Gian Matteo Pica; Hacene Zerazhi; Jan Van Droogenbroeck; Sorin Visanica; Enrique Baez de la Fuente; Brian Leber; Antonio Medina de Almeida; Dana Ranta; Jean Jacques Kiladjian; Linda Chrit; Albert Kandra; Juliane Morando; Timothy Devos;
PUBLISHED: 2019, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 60, ISSUE: 14
AUTHORS: Lynda Foltz; Gian Matteo Pica; Hacene Zerazhi; Jan Van Droogenbroeck; Sorin Visanica; Enrique Baez de la Fuente; Brian Leber; Antonio Medina de Almeida; Dana Ranta; Jean Jacques Kiladjian; Linda Chrit; Albert Kandra; Juliane Morando; Timothy Devos;
PUBLISHED: 2019, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 60, ISSUE: 14
INDEXED IN: 
Scopus 
WOS
Scopus WOS